Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.40

Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.40, versus $0.50 reported last year. Revenue for the quarter came in at $522 million, versus $505 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Independent Bank receives regulatory approval for HCB Financial acquisition
• Schwab's May activity shows margin loans nearly double